The European Vision of Community-Acquired Pneumonia

ABSTRACT

Community-acquired pneumonia is common throughout the 53 European countries. Despite differences in population structure and habits there are many similarities between countries, including overall frequency and distribution of major causative pathogens. There are, however, also differences between countries, particularly in the frequency of bacterial antibiotic resistance and to a lesser extent how the condition is managed. Having said this there are many gaps in our knowledge with little or no data available from some countries, especially those in the eastern Europe. It is hoped that future years will see these gaps filled through continuing research.

KEYWORDS

Community-acquired pneumonia - Europe - pathogens - antibiotic resistance - management

REFERENCES

• 1 Jokinen C, Heiskanen L, Juvonen H et al.. Incidence of community-acquired pneumonia in the population of four municipalities in Eastern Finland.  Am J Epidemiol. 1993;  137 977-988
• 2 Woodhead M, Blasi F, Ewig S et al.. Guidelines for the management of adult lower respiratory tract infections.  Eur Respir J. 2005;  26 1138-1180
• 3 Laurichesse H, Robin F, Gerbaud L et al.. Empirical therapy for nonhospitalized patients with community-acquired pneumonia. Study Group of General Practitioners.  Eur Respir J. 1998;  11 73-78
• 4 Almirall J, Bolibar I, Serra-Prat M et al.. New evidence of risk factors for community-acquired pneumonia: a population-based study.  Eur Respir J. 2008;  31 1274-1284
• 5 Viegi G, Pistelli R, Cazzola M et al.. Epidemiological survey on incidence and treatment of community acquired pneumonia in Italy.  Respir Med. 2006;  100 46-55
• 6 Woodhead M A, Macfarlane J T, McCracken J S, Rose D H, Finch R G. Prospective study of the aetiology and outcome of pneumonia in the community.  Lancet. 1987;  1 671-674
• 7 Schnoor M, Hedicke J, Dalhoff K, Raspe H, Schafer T. Approaches to estimate the population-based incidence of community acquired pneumonia.  J Infect. 2007;  55 233-239
• 8 Woodhead M. Epidemiology of adult hospitalized community-acquired pneumonia. In: Torres A, Menendez R Community-Acquired Pneumonia: Strategies for Management. 1st ed. Chichester; John Wiley & sons 2008: 5-19
• 9 Fine M J, Auble T E, Yealy D M et al.. A prediction rule to identify low-risk patients with community-acquired pneumonia.  N Engl J Med. 1997;  336 243-250
• 10 Gutierrez F, Masia M, Rodriguez J C et al.. Epidemiology of community-acquired pneumonia in adult patients at the dawn of the 21st century: a prospective study on the Mediterranean coast of Spain.  Clin Microbiol Infect. 2005;  11 788-800
• 11 Ortega L, Sierra M, Dominguez J et al.. Utility of a pneumonia severity index in the optimization of the diagnostic and therapeutic effort for community-acquired pneumonia.  Scand J Infect Dis. 2005;  37 657-663
• 12 Espana P P, Capelastegui A, Quintana J M et al.. A prediction rule to identify allocation of inpatient care in community-acquired pneumonia.  Eur Respir J. 2003;  21 695-701
• 13 Lim W S, van der Eerden M M, Laing R et al.. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study.  Thorax. 2003;  58 377-382
• 14 Logroscino C D, Penza O, Locicero S et al.. Community-acquired pneumonia in adults: a multicentric observational AIPO study.  Monaldi Arch Chest Dis. 1999;  54 11-17
• 15 van der Eerden M M, de Graaff C S, Bronsveld W, Jansen H M, Boersma W G. Prospective evaluation of pneumonia severity index in hospitalised patients with community-acquired pneumonia.  Respir Med. 2004;  98 872-878
• 16 Roson B, Carratala J, Dorca J, Casanova A, Manresa F, Gudiol F. Etiology, reasons for hospitalization, risk classes, and outcomes of community-acquired pneumonia in patients hospitalized on the basis of conventional admission criteria.  Clin Infect Dis. 2001;  33 158-165
• 17 Buising K L, Thursky K A, Black J F et al.. A prospective comparison of severity scores for identifying patients with severe community acquired pneumonia: reconsidering what is meant by severe pneumonia.  Thorax. 2006;  61 419-424
• 18 Holmberg H. Aetiology of community-acquired pneumonia in hospital treated patients.  Scand J Infect Dis. 1987;  19 491-501
• 19 Lorente M L, Falguera M, Nogues A, Gonzalez A R, Merino M T, Caballero M R. Diagnosis of pneumococcal pneumonia by polymerase chain reaction (PCR) in whole blood: a prospective clinical study.  Thorax. 2000;  55 133-137
• 20 Menendez R, Cordoba J, de La C P et al.. Value of the polymerase chain reaction assay in noninvasive respiratory samples for diagnosis of community-acquired pneumonia.  Am J Respir Crit Care Med. 1999;  159 1868-1873
• 21 Ruiz M, Ewig S, Marcos M A et al.. Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity.  Am J Respir Crit Care Med. 1999;  160 397-405
• 22 Ortqvist A, Hedlund J, Grillner L et al.. Aetiology, outcome and prognostic factors in community-acquired pneumonia requiring hospitalization.  Eur Respir J. 1990;  3 1105-1113
• 23 Gomez J, Banos V, Ruiz Gomez J et al.. Prospective study of epidemiology and prognostic factors in community-acquired pneumonia.  Eur J Clin Microbiol Infect Dis. 1996;  15 556-560
• 24 Macfarlane J T, Finch R G, Ward M J, Macrae A D. Hospital study of adult community-acquired pneumonia.  Lancet. 1982;  2 255-258
• 25 Lévy M, Dromer F, Brion N, Leturdu F, Carbon C. Community-acquired pneumonia. Importance of initial non-invasive bacteriologic and radiographic investigations.  Chest. 1988;  93 43-48
• 26 Berntsson E, Lagergard T, Strannegard O, Trollfors B. Etiology of community-acquired pneumonia in outpatients.  Eur J Clin Microbiol. 1986;  5 446-447
• 27 Blanquer J, Blanquer R, Borras R et al.. Aetiology of community-acquired pneumonia in Valencia, Spain: a multicentre prospective study.  Thorax. 1991;  46 508-551
• 28 Almirall J, Morato I, Riera F et al.. Incidence of community-acquired pneumonia and Chlamydia pneumoniae infection: a prospective multicentre study.  Eur Respir J. 1993;  6 14-18
• 29 Melbye H, Straume B, Aasebo U, Dale K. Diagnosis of pneumonia in adults in general practice.  Scand J Prim Health Care. 1992;  10 226-233
• 30 Michetti G, Pugliese C, Bamberga M et al.. Community-acquired pneumonia: is there difference in etiology between hospitalized and outpatients.  Minerva Med. 1995;  86 341-351
• 31 Lagerstrom F, Bader M, Foldevi M, Fredlund H, Nordin-Olsson I, Holmberg H. Microbiological etiology in clinically diagnosed community-acquired pneumonia in primary care in Orebro, Sweden.  Clin Microbiol Infect. 2003;  9 645-652
• 32 White R J, Blainey A D, Harrison K J, Clarke S KR. Causes of pneumonia presenting to a district general hospital.  Thorax. 1981;  36 566-570
• 33 McNabb W R, Shanson D C, Williams T DM, Lant A F. Adult community-acquired pneumonia in central London.  J R Soc Med. 1984;  77 550-555
• 34 British Thoracic Society . Community-acquired pneumonia in adults in British hospitals in 1982–1983: a survey of aetiology, mortality, prognostic factors and outcome.  Q J Med. 1987;  62 195-220
• 35 Lim W S, Macfarlane J T, Boswell T C et al.. Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines.  Thorax. 2001;  56 296-301
• 36 Howard L S, Sillis M, Pasteur M C, Kamath A V, Harrison B D. Microbiological profile of community-acquired pneumonia in adults over the last 20 years.  J Infect. 2005;  50 107-113
• 37 Berntsson E, Blomberg J, Lagergard T, Trollfors B. Etiology of community-acquired pneumonia in patients requiring hospitalization.  Eur J Clin Microbiol. 1985;  4 268-272
• 38 Burman L A, Trollfors B, Andersson B et al.. Diagnosis of pneumonia by cultures, bacterial and viral antigen detection tests, and serology with special reference to antibodies against pneumococcal antigens.  J Infect Dis. 1991;  163 1087-1093
• 39 Ostergaard L, Andersen P L. Etiology of community-acquired pneumonia: evaluation by transtracheal aspiration, blood culture or serology.  Chest. 1993;  104 1400-1407
• 40 Ausina V, Coll P, Sambeat M et al.. Prospective study on the etiology of community-acquired pneumonia in children and adults in Spain.  Eur J Clin Microbiol Infect Dis. 1988;  7 342-347
• 41 Falco V, Fernandez de Sevilla T, Alegre J, Ferrer A, Vazquez J MM. Legionella pneumophila: a cause of severe community-acquired pneumonia.  Chest. 1991;  100 1007-1011
• 42 Pareja A, Bernal C, Leyva A, Piedrola G, Maroto M C. Etiologic study of patients with community-acquired pneumonia.  Chest. 1992;  101 1207-1210
• 43 Sopena N, Sabria M, Pedro-Botet M L et al.. Prospective study of community-acquired pneumonia of bacterial etiology in adults.  Eur J Clin Microbiol Infect Dis. 1999;  18 852-858
• 44 Arancibia F, Bauer T T, Ewig S et al.. Community-acquired pneumonia due to gram-negative bacteria and Pseudomonas aeruginosa: incidence, risk, and prognosis.  Arch Intern Med. 2002;  162 1849-1858
• 45 Marcos M A, Jimenez de Anta M T, de la Bellacasa J P et al.. Rapid urinary antigen test for diagnosis of pneumococcal community-acquired pneumonia in adults.  Eur Respir J. 2003;  21 209-214
• 46 Fernández Alvarez R, Suárez Toste I, Rubinos Cuadrado G et al.. Community-acquired pneumonia: aetiologic changes in a limited geographic area: an 11-year prospective study.  Eur J Clin Microbiol Infect Dis. 2007;  26 495-499
• 47 Blasi F, Cosentini R, Raccanelli R et al.. Emerging pathogens of community-acquired pneumonia: a two-year prospective study.  J Chemother. 1995;  7(Suppl 4) 115-116
• 48 Aubertin J, Dabis F, Fleurette J et al.. Prevalence of legionellosis among adults: a study of community-acquired pneumonia in France.  Infection. 1987;  15 328-331
• 49 Woodhead M A, Macfarlane J T, Rodgers F G, Laverick A, Pilkington R, Macrae A D. Aetiology and outcome of severe community-acquired pneumonia.  J Infect. 1985;  10 204-210
• 50 Alkhayer M, Jenkins P F, Harrison B DW. The outcome of community-acquired pneumonia treated on the intensive care unit.  Respir Med. 1990;  84 13-16
• 51 British Thoracic Society Research committee . The aetiology, management and outcome of severe community-acquired pneumonia on the intensive care unit.  Respir Med. 1992;  86 7-13
• 52 Hirani N A, Macfarlane J T. Impact of management guidelines on the outcome of severe community acquired pneumonia.  Thorax. 1997;  52 17-21
• 53 Ortqvist A, Sterner G, Nilsson J A. Severe community-acquired pneumonia: factors influencing need of intensive care treatment and prognosis.  Scand J Infect Dis. 1985;  17 377-386
• 54 Sorensen J, Forsberg P, Hakanson E et al.. A new diagnostic approach to the patient with severe pneumonia.  Scand J Infect Dis. 1989;  21 33-41
• 55 Pachon J, Prados M D, Capote F, Cuello J A, Garnacho J, Verano A. Severe community-acquired pneumonia: etiology, prognosis and treatment.  Am Rev Respir Dis. 1990;  142 369-373
• 56 Torres A, Serra-batlles J, Ferrer A et al.. Severe community-acquired pneumonia: epidemiology and prognostic factors.  Am Rev Respir Dis. 1991;  144 312-318
• 57 Rello J, Quintana E, Ausina V, Net A, Prats G. A three year study of severe community-acquired pneumonia with emphasis on outcome.  Chest. 1993;  103 232-235
• 58 Almirall J, Mesalles E, Klamburg J, Parra O, Agudo A. Prognostic factors of pneumonia requiring admission to the intensive care unit.  Chest. 1995;  107 511-516
• 59 Olaechea P M, Quintana J M, Gallardo M S, Insausti J, Maravi E, Alvarez B. A predictive model for the treatment approach to community-acquired pneumonia in patients needing ICU admission.  Intensive Care Med. 1996;  22 1294-1300
• 60 Leroy O, Santre C, Beuscart C et al.. A five year study of severe community-acquired pneumonia with emphasis on prognosis in patients admitted to an intensive care unit.  Intensive Care Med. 1995;  21 24-31
• 61 Moine P, Vercken J-P, Chevret S, Chastang C, Gajdos P. French study group for community-acquired pneumonia in the intensive care unit: severe community-acquired pneumonia: etiology, epidemiology and prognosis factors.  Chest. 1994;  105 1487-1495
• 62 Wellinghausen N, Straube E, Freidank H, von Baum H, Marre R, Essig A. Low prevalence of Chlamydia pneumoniae in adults with community-acquired pneumonia.  Int J Med Microbiol. 2006;  296 485-491
• 63 Socan M, Marinic-Fiser N, Kraigher A, Kotnik A, Logar M. Microbial aetiology of community-acquired pneumonia in hospitalised patients.  Eur J Clin Microbiol Infect Dis. 1999;  18 777-782
• 64 Leesik H, Ani U, Juhani A, Altraja A. Microbial pathogens of adult community-acquired pneumonia in Southern Estonia.  Medicina (Kaunas). 2006;  42 384-394
• 65 EARSS Management Team .EARSS Annual Report 2006. Bilthoven, the Netherlands; EARSS 2007
• 66 Riedel S, Beekmann S E, Heilmann K P et al.. Antimicrobial use in Europe and antimicrobial resistance in Streptococcus pneumoniae .  Eur J Clin Microbiol Infect Dis. 2007;  26 485-490
• 67 Goossens H, Ferech M, Vander S R, Elseviers M. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study.  Lancet. 2005;  365 579-587
• 68 Huchon G J, Gialdroni Grassi G, Leophonte P, Manresa F, Schaberg T, Woodhead M. Initial antibiotic therapy for lower respiratory tract infection in the community: a European survey.  Eur Respir J. 1996;  9 1590-1595
• 69 Kohlhammer Y, Raspe H, Marre R, Suttorp N, Welte T, Schafer T. Antibiotic treatment of community acquired pneumonia varies widely across Germany.  J Infect. 2007;  54 446-453
• 70 Capelastegui A, Espana P P, Quintana J M et al.. Management of community-acquired pneumonia and secular trends at different hospitals.  Respir Med. 2005;  99 268-278
• 71 Hedlund J, Ortqvist A, Ahlqvist T et al.. Management of patients with community-acquired pneumonia treated in hospital in Sweden.  Scand J Infect Dis. 2002;  34 887-892
• 72 Schouten J A, Prins J M, Bonten M et al.. Optimizing the antibiotics policy in the Netherlands, VIII: Revised SWAB guidelines for antimicrobial therapy in adults with community-acquired pneumonia.  Ned Tijdschr Geneeskd. 2005;  149 2495-2500
• 73 Alfageme I, Aspa J, Bello S et al.. Guidelines for the diagnosis and management of community-acquired pneumonia. Spanish Society of Pulmonology and Thoracic Surgery (SEPAR).  Arch Bronconeumol. 2005;  41 272-289
• 74 Hedlund J, Stralin K, Ortqvist A, Holmberg H. Swedish guidelines for the management of community-acquired pneumonia in immunocompetent adults.  Scand J Infect Dis. 2005;  37 791-805
• 75 BTS Pneumonia Guidelines Committee .BTS guidelines for the management of community-acquired pneumonia in adults—2004 update. Available at: http://www.brit-thoracic.org.uk/Portals/0/Clinical%20Information/Pneumonia/Guidelines/MACAPrevisedApr04.pdf 2004
• 76 Hoffken G, Lorenz J, Kern W et al.. S3-guideline on ambulant acquired pneumonia and deep airway infections.  Pneumologie. 2005;  59 612-664